Abstract:Background: Preadipocyte factor-1 (Pref-1), an inhibitor of adipocyte differentiation, is increased in fetal blood of small for gestational age (SGA) and is considered a factor involved in determining adiposity and associated with high risk of metabolic diseases in adulthood. Preeclampsia is a condition closely associated with SGA, however, the alteration of Pref-1 of in fetuses of preeclampsia-remains unknown. The aims of the current investigation were to clarify the alteration of serum Pref-1 in fetuses of preeclamptic pregnancy and to explore possible role of Pref-1 in metabolic diseases in late life.Methods: Cord blood samples were taken at birth from 45 fetuses of normal pregnancy, 16 of gestational hypertension, 29 of mild preeclampsia and 29 of severe preeclampsia. Serum Pref-1 concentrations were measured with ELISA.Results: There were significant differences in cord blood Pref-1 and neonatal birth weight among normal pregnancy, gestational hypertension, mild and severe preeclampsia (F = 8.557, P < 0.001 for Pref-1; F = 38.405, P < 0.001 for birth weight). Serum Pref-1 was significantly higher while birth weight were lower in severe preeclampsia than normal pregnancy, gestational hypertension and mild preeclampsia respectively (P < =0.001 for all). However, either serum Pref-1 or birth weight did not significantly differ among normal pregnancy, gestational hypertension and mild preeclampsia (P > 0.05 for all). Fetal Pref-1 concentration was significantly negatively correlated with birth weight (R-2 = 0.175, P = 0.027 for severe preeclampsia; R-2 = 0.209, P < 0.001 for preeclampsia; R-2 = 0.25, P < 0.001 for all subjects).Conclusions: Increased serum Pref-1 was demonstrated in fetuses of preeclampsia-complicated pregnancy, and it may be proposed that Pref-1 is among the possible mediators leading to high risk of metabolic diseases in adulthood. (c) 2013 Elsevier B.V. All rights reserved.

Serum visfatin levels in late pregnancy and pre-eclampsia.

Correlations of Serum Visfatin and Metabolisms of Glucose and Lipid in Women with Gestational Diabetes Mellitus

Serum Adiponectin, Leptin and Soluble Leptin Receptor in Pre-Eclampsia.

A Research on Correlation between Serum Visfatin and Glucose and Lipid Metabolism among Women with Gestational Diabetes Mellitus

Serum Follistatin-Like-3 Was Elevated in Second Trimester of Pregnant Women Who Subsequently Developed Preeclampsia

Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus.

The changes and significance of serum visfatin levels in patients with preeclampsia

Alterations Of Serum Resistin In Normal Pregnancy And Pre-Eclampsia

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Serum Preadipocyte Factor-1 is Increased in Fetuses of Pregnancy Complicated with Severe Preeclampsia.

Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Relationship Between Serum Resistin Level and Preeclampsia

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Study On The Correlation Between Adipocyte Fatty-Acid Binding Protein, Glucolipid Metabolism, And Pre-Eclampsia

Paradoxical devation of senna adiponectin and its relationship with the level of serum leptin in preeclampsia

The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes.

Alteration of Serum Adropin Level in Preeclampsia.

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Serum Protein Marker Panel for Predicting Preeclampsia.

Alteration of Serum Endocan in Normal Pregnancy and Preeclampsia